- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/04 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 251/04
Total number of patents in this class: 63
10-year publication summary
2
|
3
|
3
|
6
|
3
|
14
|
7
|
4
|
4
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Contemporary Amperex Technology (Hong Kong) Limited | 3443 |
13 |
BASF SE | 20892 |
3 |
International Business Machines Corporation | 61185 |
3 |
Merck Patent GmbH | 5873 |
3 |
Dow Global Technologies LLC | 10401 |
3 |
Flexsys America L.P. | 30 |
3 |
Flexsys IP Holdings, LLC | 14 |
3 |
Idemitsu Kosan Co., Ltd. | 4208 |
2 |
Hydro-Quebec | 649 |
2 |
Sika Technology AG | 2855 |
2 |
Sunvax Mrna Therapeutics Inc. | 8 |
2 |
General Electric Company | 13829 |
1 |
ExxonMobil Research And Engineering Company | 2585 |
1 |
Allergan, Inc. | 2356 |
1 |
Samsung SDI Co., Ltd. | 8140 |
1 |
Sumitomo Chemical Company, Limited | 9031 |
1 |
Alliance for Sustainable Energy, LLC | 796 |
1 |
Astellas Pharma Inc. | 1088 |
1 |
Biogen MA Inc. | 893 |
1 |
Ceca S.A. | 46 |
1 |
Other owners | 15 |